AlphaMa is a pioneering drug R&D company based in Suzhou, China, established in 2018. With artificial intelligence (AI) as the driving technology, DNA-encoded library (DEL) technology is cross-applied to establish a cutting-edge Intelligent DEL (iDEL) platform(including the first-class technology of on-demand DEL synthesis, DEL screening, hit confirmation, macrocyclic peptide DELs, customized glue library, etc.). The iDEL platform at AlphaMa features first-class DNA-encoded library (DEL) technology specializing in small molecule, macrocyclic peptide and covalent hit discovery, etc. With its mature screening technology and high success rate, providing global partners with a cost-effective and efficient one-stop DEL screening service. Our flexible service model, diversified services and excellent service system cover all stages of early drug discovery. We provide flexible and cost-effective approaches to meet customers' diverse needs with professional technology and high-quality services. AlphaMa is your ideal partner for drug discovery, assisting you in accelerating the drug discovery process. Reach out to learn more: liuyulin@aiphama.cn
Company Details
- Employees
- 7
- Address
- No. 108, Yuxin Road, Suzhou Industrial Park, Suzhou,jiangsu 215128,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.alphama.com.cn/en/
- Keywords
- model.
- HQ
- Suzhou, Jiangsu
Alphama Questions
Alphama's website is https://www.alphama.com.cn/en/
Alphama's LinkedIn profile is https://cn.linkedin.com/company/alphama
Alphama has
7 employees.
View email and phone details for 7
employees at Alphama.
Alphama's industry is
Biotechnology Research
Alphama's top competitors are
Moleculeinsight,
Peptifinder Biotech, Inc,
Alphamar,
Protonunfold Inc.,
Delscovery Llc,
Macroceutics, Inc.,
Chem-Impex International, Inc.,
Calibra Scientific Inc.,
Alphama Group,
Alphamath.
Alphama's categories are Biotechnology Research
